Methods of treatment using amphetamine controlled release, prodrug, and abuse deterrent dosage forms
US11717498B2 · kind B2 · utility
0Cited by
13References
32Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 9, 2020 |
| Grant date | Aug 8, 2023 |
| Priority date | — |
| Expiry date | Oct 9, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/64
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention also relates to pharmaceutical compositions comprising highly pure amphetamine and amphetamine-class compounds resulting from the synthesis of chiral and racemic amphetamine derivatives by stereospecific, regioselective cuprate addition reaction with aziridine phosphoramidate compounds, and to methods of manufacturing, delivering, and using the amphetamine compounds resulting from the synthesis of chiral and racemic amphetamine derivatives by stereospecific, regioselective cuprate addition reaction with aziridine phosphoramidate compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.